Skip to main content
Log in

Alterations in the regulation of expression of the αl(I) collagen gene (COL1A1) in systemic sclerosis (scleroderma)

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

Summary

At present, the mechanisms that regulate the expression of collagen genes in normal and pathologic fibroblasts are not known. Thus, the detailed study of transcriptional regulation of COL1A1 in SSc cells will increase our current understanding of the pathophysiology of fibrotic diseases. These studies will yield valuable information regarding the important biological process of regulation of collagen gene expression under normal and pathologic conditions, a process that has remained elusive despite intense recent investigations.

It is now evident that persistent overproduction of collagen is responsible for the progressive nature of tissue fibrosis in SSc. Up-regulation of collagen gene expression in SSc fibroblasts appears to be a critical event in this process. The coordinate transcriptional activation of numerous collagen genes suggests a fundamental alteration in the regulatory control of gene expression in SSc fibroblasts. Trans-acting nuclear factors which bind to cis-acting elements in enhancer (intronic) and promoter regions of the genes modulate the basal and inducible transcriptional activity of the collagen genes. The identification of the nuclear transcription factors that regulate normal collagen gene expression may provide promising approaches to the therapy of this incurable disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Artlett CM, Chen S-J, Varga J, Jimenez SA (1998) Modulation of basal expression of the human αl(I) procollagen gene (COL1A1) by tandem NF-1/Sp1 promoter elements in normal human dermal fibroblasts. Matrix Biol 171:425

    Article  Google Scholar 

  2. Batuman OA, Jimenez SA (1993) Systemic sclerosis. In: Bona CA, Siminovitch KA, Zanetti M, Theofilopoulos AN (eds) The molecular pathology of autoinunune diseases. Harwood, Chur, pp 377–399

    Google Scholar 

  3. Boast S, Su MW, Ramirez F, Sanchez M, Avvedimento EV (1990) Functional analysis ofcis-acting DNA sequences controlling transcription of the human type I collagen genes. J Biol Chem 265:13351

    PubMed  CAS  Google Scholar 

  4. Bornstein P, McKay J, Morishima JK, Devarayalu S, Gelinas RE (1987) Regulatory elements in the first intron contribute to transcriptional control of the human α1(I) collagen gene. Proc Natl Acad Sci USA 84:8869

    Article  PubMed  CAS  Google Scholar 

  5. Bornstein P, McKay J (1988) The first intron of the α1 (I) collagen gene contains several transcriptional regulatory elements. J Biol Chem 263:1603

    PubMed  CAS  Google Scholar 

  6. Bornstein P, McKay J, Liska DJ, Apone S, Devarayalu S (1988) Interactions between the promoter and first intron are involved in transcriptional control of α1(I) collagen gene expression. Mot Cell Biol 8:4851

    CAS  Google Scholar 

  7. Bornstein P (1996) Regulation of expression of the α1(I) collagen gene: a critical appraisal of the role of the first intron. Matrix Biol 15:3

    Article  PubMed  CAS  Google Scholar 

  8. Chavrier P, Lemair P, Revelant O, Bravo R, Charnay P (1988) Characterization of a mouse multigene family that encodes zinc finger structures. Mot Cell Biol 8:1319

    CAS  Google Scholar 

  9. Chen S-J, Artlett CM, Jimenez SA, Varga J (1998) Modulation of human α1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitro. Gene 215:101

    Article  PubMed  CAS  Google Scholar 

  10. Chen S-J, Yuan W, Mori Y, Levenson A, Trojanowska M, Varga J (1999) Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β: involvement of Smad 3. J Invest Dermatol 112:49

    Article  PubMed  CAS  Google Scholar 

  11. Chu M-L, DeWet W, Ramirez F (1985) Fine structural analysis of the human pro-α1(I) collagen gene. J Biol Chem 260:2315

    PubMed  CAS  Google Scholar 

  12. Chung KY, Agarwal A, Uitto J, Mauviel A (1996) An AP-1 binding sequence is essential for regulation of the human α2(I) collagen (COL1A2) promoter activity by transforming growth factor-β. J Biol Chem 271:3277

    Google Scholar 

  13. Claman HN, Giorno RC, Seibold JR (1991) Endothelial and fibroblast activation in scleroderma. The myth of the “uninvolved skin.” Arthritis Rheum 34:1495

    PubMed  CAS  Google Scholar 

  14. Courey AJ, Tjian R (1988) Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel gtutamine-rich activation domain. Cell 55:887

    Article  PubMed  CAS  Google Scholar 

  15. Coustry F, Sinha S, Maity SN, de Crombrugghe B (1998) The two activation domains of the CCAAT-binding factor CBF interact with the dTAFII110 component of theDrosophila TFIID complex. Biochem J 331:291

    PubMed  CAS  Google Scholar 

  16. D'Angelo WA, Fries JF, Masi AT, Shulman LE (1969) Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 46:428

    Article  PubMed  Google Scholar 

  17. Eckes B, Mauch C, Huppe G, Krieg T (1996) Differential regulation of transcription and transcript stability of proα1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic sclerosis. Biochem J 315:549

    PubMed  CAS  Google Scholar 

  18. Elgin SCR (1984) Anatomy of DNA hypersensitive sites. Nature 309:213

    Article  PubMed  CAS  Google Scholar 

  19. Galera P, Musso M, Ducy P, Karsenty G (1994) c-Krox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin. Proc Natl Acad Sci USA 91:9372

    Article  PubMed  CAS  Google Scholar 

  20. Galera P, Park RW, Duey P, Mattei MG, Karsenty G (1996) c-Krox binds to several sites in the promoter of both mouse type I collagen genes. J Biol Chem 271:21331

    Article  PubMed  CAS  Google Scholar 

  21. Grant SFA, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH (1996) Reduced bone density and osteoporosis associated with a polymorpbic Sp1 binding site in the collagen type I αl gene. Nature Genet 14:203

    Article  PubMed  CAS  Google Scholar 

  22. Greenwel P, Hu W, Kohanski RA, Ramirez F (1995) Tyrosine dephosphorylation of nuclear proteins mimics transforming growth factor β1 stimulation of α2(1) collagen gene expression. Mol Cell Biol 15:6813

    PubMed  CAS  Google Scholar 

  23. Handerbol P, Van Dyke MW (1992) In vitro inhibition of c-myc transcription by mithramycin. Biochem Biophys Res Common 185:553

    Article  Google Scholar 

  24. Herrmann K, Heckmann M, Kulozik M, Haustein UF, Krieg T (1991) Steady-state mRNA levels of collagens I, III, fibronectin, and collagenase in skin biopsies of systemic sclerosis patients. J Invest Dermatol 97:219

    Article  PubMed  CAS  Google Scholar 

  25. Hitraya EG, Jimenez SA (1996) Transcriptional activation of the α(I) procollagen gene in systemic sclerosis dermal fibroblasts: role of intronic sequences. Arthritis Rheum 39:1347

    Article  PubMed  CAS  Google Scholar 

  26. Hitraya EG, Varga J, Artlett CM, Jimenez SA (1998) Identification of elements in the promoter of the α1(I) procollagen gene involved in its upregulated expression in systemic sclerosis. Arthritis Rheum 41:2048

    Article  PubMed  CAS  Google Scholar 

  27. Hormuzdi SG, Penttinen R, Jaenish R, Bornstein P (1998) A gene targeting approach identifies a function for the first intron in expression of the α1(I) collagen gene. Mol Cell Biol 18:3368

    PubMed  CAS  Google Scholar 

  28. Ihn H, Ohnishi K, Tamaki T, LeRoy EC, Trojanowska M (1996) Transcriptional regulation of the human α2(I) collagen gene. J Biol Chem 271:26717

    Article  PubMed  CAS  Google Scholar 

  29. Ihn H, Trojanowska M (1997) Sp3 is a transcriptional activator of the human α2(I) collagen gene. Nucleic Acids Res 25:3712

    Article  PubMed  CAS  Google Scholar 

  30. Inagaki Y, Truter S, Ramirez F (1994) Transforming growth factor-β stimulates α2(I) collagen gene expression through acis-acting element that contains an Sp1-binding site. J Biol Chem 269:14826

    Google Scholar 

  31. Jimenez SA, Yankowski RI, Frontino PM (1977) Biosynthetic heterogeneity of sclerodermatous skin in organ cultures. J Mol Med 2:423

    CAS  Google Scholar 

  32. Jimenez SA, Feldman G, Bashey RI, Bienkowski R, Rosenbloom J (1986) Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis. Biochem J 237:837

    PubMed  CAS  Google Scholar 

  33. Jimenez SA, Varga J, Olsen A, Li L, Diaz A, Herhal J, Koch J (1994) Functional analysis of human α1(I) procollagen gene promoter. Differential activity in collagen-producing and non-producing cells and response to transforming growth factor-β1. J Biol Chem 269:12684

    PubMed  CAS  Google Scholar 

  34. Kadonaga JT, Carrier KK, Masairz FR, Tjian R (1987) Isolation of cDNA encoding transcription factor Sp 1 and functional analysis of the DNA binding domain. Cell 51:1079

    Article  PubMed  CAS  Google Scholar 

  35. Kähäri V, Vuorio T, Nanto-Salonen K, Vuorio E (1984) Increased type I collagen mRNA levels in cultured scleroderma fibroblasts. Biochim Biophys Acta 781:183

    PubMed  Google Scholar 

  36. Kähäri V-M, Multimaki P, Vuorio E (1987) Elevated pro-α2(I) collagen mRNA levels in cultured scleroderma fibroblasts result from an increased transcription rate of the corresponding gene. FEBS Lett 215:331

    Article  PubMed  Google Scholar 

  37. Kähäri V-M, Heino J, Vuorio T, Vuorio E (1988) Interferon-γ and -α reduce excessive collagen synthesis and procollagen mRNA levels of scleroderma fibroblasts in culture. Biochim Biophys Acta 968:45

    Article  PubMed  Google Scholar 

  38. Kähäri V-M, Sandberg M, Kalimo H, Vuorio T, Vuorio E (1988) Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization. J Invest Dermatol 90:664

    Article  PubMed  Google Scholar 

  39. Karsenty G, deCrombrugghe B (1990) Two different negative and one positive regulatory factors interact with a short promoter segment of the α1(I) collagen gene. J Biol Chem 265:9934

    PubMed  CAS  Google Scholar 

  40. Karsenty G, Ravazzolo R, deCrombrugghe B (1992) Purification and functional characterization of a DNA-binding protein that interacts with a negative element in the mouse α1(I) collagen promoter. J Biol Chem 266:24842

    Google Scholar 

  41. Karsenty G, Park RW (1995) Regulation of type I collagen genes expression. Int Rev Immunol 12:177

    Article  PubMed  CAS  Google Scholar 

  42. Katai H, Stephenson JD, Simkevich CP, Thompson JP, Raghow R (1992) An AP-1-like motif in the first intron of human pro-α1(I) collagen gene is a critical determinant of its transcriptional activity. Mol Cell Biochem 118:119

    Article  PubMed  CAS  Google Scholar 

  43. Kikuchi K, Smith EA, LeRoy EC, Trojanowska M (1992) Direct demonstration of transcriptional activation of collagen gene expression is systemic sclerosis fibroblasts. Biochem Biophys Res Common 187:45

    Article  CAS  Google Scholar 

  44. Knippe DC, Seifert E, Rosenberg UB, Preiss A, Jackle H (1985) Spatial and temporal patterns of Kruppel gene expression in early Drosophila embryos. Nature 317:40

    Article  Google Scholar 

  45. Kouba DJ, Chung KY, Nishiyama T, Vindevoghel L, Kon A, Klement JF, Uitto J, Mauviel A (1999) Nuclear factor-kappa B mediates TNF-α inhibitory effect on α2(I) collagen (COL 1A2) gene transcription in human dermal fibroblasts. J Immunol 162:4226

    PubMed  CAS  Google Scholar 

  46. Kulozik M, Hogg A, Lankat-Buttgereit B, Krieg T (1990) Co-localization of transforming growth factor-β2 with α1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest 86:917

    Article  PubMed  CAS  Google Scholar 

  47. LeRoy EC (1974) Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest 54:880

    Article  PubMed  CAS  Google Scholar 

  48. Li L, Artlett CM, Jimenez SA, Hall DJ, Varga J (1995) Positive regulation of human α1(I) collagen promoter activity by transcription factor Sp1. Gene 164:229

    Article  PubMed  CAS  Google Scholar 

  49. Liau G, Szapary D, Setoyama C, deCrombrugghe B (1986) Restriction enzyme digestions identify discrete domains in the chromatin around the promoter of the mouse α2(I) collagen gene. J Biol Chem 261:11362

    PubMed  CAS  Google Scholar 

  50. Liska DJ, Slack JL, Bornstein P (1990) A highly conserved intronic sequence is involved in transcriptional regulation of the α1(I) collagen gene. Cell Regulation 1:487

    PubMed  CAS  Google Scholar 

  51. Lovell C, Nicholls A, Duance V, Bailey AJ (1979) Characterization of dermal collagen in systemic sclerosis. Br J Dermatol 100:359

    Article  PubMed  CAS  Google Scholar 

  52. McKeon C, Ohkubo H, Pastan I, deCrombrugghe B (1982) Unusual methylation pattern of the α2(I) collagen gene. Cell 29:203

    Article  PubMed  CAS  Google Scholar 

  53. Medsger TA Jr (1997) Systemic Sclerosis (Scleroderma): clinical aspects. In: McCarty DJ, Koopman WJ (eds) Arthritis and allied conditions. Williams Wilkins, Baltimore, pp 1433–1463

    Google Scholar 

  54. Mori K, Hatamochi A, Ueki H, Olsen A, Jimenez SA (1996) The transcription of human α1(I) procollagen gene (COL1A1) is suppressed by tumour necrosis factor-α through proximal short promoter elements: evidence for suppression mechanisms mediated by two nuclear-factor binding sites. Biochem J 319:811

    PubMed  CAS  Google Scholar 

  55. Nehls MC, Rippe RA, Veloz L, Brenner DA (1991) Transcription factors nuclear factor I and Sp1 interact with the murine collagen α1(I) promoter. Mol Cell Biol 11:4065

    PubMed  CAS  Google Scholar 

  56. Nehls MC, Grapilon ML, Brenner DA (1992) NF-1/Sp1 switch elements regulate collagen α1(I) gene expression. DNA Cell Biol 11:443

    Article  PubMed  CAS  Google Scholar 

  57. Nehls MC, Brenner DA, Gruss HJ, Dierbach H, Mertelsmann R, Herrmann I (1993) Mithramycin selectively inhibits collagen α1(I) gene expression in human fibroblast. J Clin Invest 92:2916

    Article  PubMed  CAS  Google Scholar 

  58. Olsen AS, Geddis AE, Prockop DJ (1991) High levels of expression of a minigene version of the human pro-α1(I) collagen gene in stably transfected mouse fibroblasts. J Biol Chem 266:1117

    PubMed  CAS  Google Scholar 

  59. Peltonen J, Käh→i L, Jaakkola S, Kähäri VM, Varga J, Uitto J, Jimenez SA (1989) Evaluation of transforming growth factor β1 and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization. J Invest Dermatol 94:365

    Article  Google Scholar 

  60. Peltonen J, Kähäri L, Uitto J, Jimenez SA (1990) Increased expression of type VI collagen genes in progressive systemic sclerosis lesions in situ. Arthritis Rheum 33:1829

    Article  PubMed  CAS  Google Scholar 

  61. Peterkofsky B, Gosiewska A, Kingh K, Pearlman S, Mahmoodian F (1999) Species differences in cis-elements of the proα1(I) procollagen promoter and their binding proteins. J Cell Biochem 73:408

    Article  PubMed  CAS  Google Scholar 

  62. Pogulis PJ, Freitag SV (1993) Contribution of specific cis-acting elements to activity of the mouse proα2(I) enhancer. J Biol Chem 268:2493

    PubMed  CAS  Google Scholar 

  63. Poppleton HM, Raghow R (1997) Transcriptional activation of the minimal human proα1(I) collagen promoter: obligatory requirement for Sp1. Biochem J 323:225

    PubMed  CAS  Google Scholar 

  64. Ray R, Snyder RC, Thomas S, Koller CA, Miller DM (1989) Mithramycin blocks protein binding and function of the SV40 early promoter. J Clin Invest 83:2003

    Article  PubMed  CAS  Google Scholar 

  65. Rippe RA, Almounajed G, Brenner D (1995) Sp1 binding activity increases in activated Ito cells. Hepatology 22:241

    PubMed  CAS  Google Scholar 

  66. Ritzenthaler JD, Goldstein RH, Fine A, Lichtler A, Rowe DW, Smith BD (1991) Transforming-growth-factor-β activation elements in the distal promoter regions of the rat α1 type I collagen gene. Biochem J 280:157

    PubMed  CAS  Google Scholar 

  67. Ritzenthaler JD, Goldstein RH, Fine A, Smith BD (1993) Regulation of the alpha 1(I) collagen promoter via a transforming growth factor-beta activation element. J Biol Chem 268:13625

    PubMed  CAS  Google Scholar 

  68. Rodnan G, Lipinski E, Luksick J (1979) Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 22:130

    Article  PubMed  CAS  Google Scholar 

  69. Roussouw CM, Vergeer WP, duPlooy SJ, Bernard MP, Ramirez D, deWet WJ (1987) DNA sequences in the first intron of the human proα1(I) collagen gene enhance transcription. J Biol Chem 262:15151

    Google Scholar 

  70. Rudnicka L, Varga J, Christiano AM, Iozzo RV, Jimenez SA, Unto J (1994) Elevated expression of type VII collagen in the skin of patients with systemic sclerosis: regulation by transforming growth factor-β. J Clin Invest 93:1709

    Article  PubMed  CAS  Google Scholar 

  71. Sackner MA (1966) Scleroderma, modern medical monographs. Grune Stratton, New York

    Google Scholar 

  72. Sherwood AL, Bornstein P (1990) Transcriptional control of the α1(I) collagen gene involves orientation- and position-specific intronic sequences. Biochem J 265:895

    PubMed  CAS  Google Scholar 

  73. Slack JL, Liska DJ, Bornstein P (1993) Regulation of expression of the type I collagen genes. Am J Med Genet 45:140

    Article  PubMed  CAS  Google Scholar 

  74. Snyder RC, Ray R, Blume S, Miller DM (1991) Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. Biochemistry 30:4290

    Article  PubMed  CAS  Google Scholar 

  75. Sokolov BP, Ala-Kokko L, Dhulipala R, Arita M, Khillan JS, Prockop DJ (1995) Tissue-specific expression of the gene for type I procollagen (COL1A1) in transgenic mice. Only 476 base pairs of the promoter are required if collagen genes are used as reporters. J Biol Chem 270:9622

    Article  PubMed  CAS  Google Scholar 

  76. Tamaki T, Ohnishi K, Hard C, LeRoy EC, Trojanowska M (1995) Characterization of GC-rich region containing Sp1 binding site(s) as a constitutive responsive element of the α2(I) collagen gene in human fibroblasts. J Biol Chem 270:4299

    Article  PubMed  CAS  Google Scholar 

  77. Thompson JP, Simkevich CP, Holness MA, Kang AIL, Raghow R (1991) In vitro methylation of the promoter and enhancer of proα1(I) collagen gene leads to its transcriptional inactivation. J Biol Chem 266:2549

    PubMed  CAS  Google Scholar 

  78. Uitto J, Helin P, Rasmussen O, Lorenzen I (1970) Skin collagen in patients with scleroderma: biosynthesis and maturation in vitro and the effect ofd-penicillamine. Ann Clin Res 2:228

    PubMed  CAS  Google Scholar 

  79. Uitto J, Bauer EA, Eisen AZ (1979) Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. J Clin Invest 64:921

    Article  PubMed  CAS  Google Scholar 

  80. Widom RL, Culic I, Lee JY, Korn JH (1997) Cloning and characterization of hcKrox, a transcriptional regulator of extracellular matrix gene expression. Gene 198:407

    Article  PubMed  CAS  Google Scholar 

  81. Yuan W, Yufit T, Li L, Mori Y, Chen SJ, Varga J (1999) Negative modulation of α1(I) procollagen gene expression in human skin fibroblasts: transcriptional inhibition by interferon-gamma. J Cell Physiol 179:97

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sergio A. Jimenez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jimenez, S.A., Saitta, B. Alterations in the regulation of expression of the αl(I) collagen gene (COL1A1) in systemic sclerosis (scleroderma). Springer Semin Immunopathol 21, 397–414 (2000). https://doi.org/10.1007/BF00870302

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00870302

Keywords

Navigation